HC Wainwright maintains Buy on Vir Biotechnology, $22 target
HC Wainwright & Co. reiterated a Buy rating on Vir Biotechnology and kept its $22.00 price target.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.